Mobia Medical, Inc. (MOBI) Stock Price & Analysis
Mobia Medical, Inc. (MOBI) closed at USD 8.31 on Thursday, October 15, 2026, down 0.60% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 8.36; the Oct 15, 2026 session ranged USD 8.25–8.42 on volume of 65,772 shares. Market capitalization is $276.65M, with a 52-week range of USD 8.16–15.29 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MOBI.md
Key facts (MOBI)
- Analysts: Buy (mean 1.75 on a 1–5 scale) (4 analysts), mean target USD 17.75 (range 16–19).
- Total return with dividends: 1Y -29.3% vs S&P 500 +18.1%; 5Y -29.3% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.48, revenue estimate $14.0M.
Analysts (MOBI)
Consensus Buy (mean 1.75 on a 1–5 scale), 4 analysts; mean target USD 17.75 (low 16, high 19).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-12 | JP Morgan | Target raised | Overweight | $15 → $17 |
| 2026-08-12 | BTIG | Reiterated | Buy | $19 |
Total return (dividends reinvested) (MOBI)
| 1Y (from 2026-05-08) | 5Y (from 2026-05-04) | |
|---|---|---|
| Total return | -29.3% | -29.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 72.3% | 55.1% |
| Max drawdown | -43.2% (Jun 2026→Oct 2026) | -43.2% (Jun 2026→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 8.31 |
|---|---|
| Change | ▼ 0.60% (down) |
| Previous Close | USD 8.36 |
| Open | USD 8.36 |
| Day Range | USD 8.25 – 8.42 |
| 52-Week Range | USD 8.16 – 15.29 |
| Volume | 65,772 shares |
| Market Cap | $276.65M |
| Exchange | NMS |
Technical Analysis (MOBI)
Nexqual's technical model rates MOBI "SELL" based on 1 bullish and 5 bearish signals across 111 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.48 (neutral) |
| vs SMA50 | Below (USD 10.38) |
| MACD | -0.57 (negative) |
Analyst Ratings (MOBI)
Wall Street analysts rate MOBI "Buy" based on 4 analysts, with a mean price target of USD 17.75 (range USD 16–19), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 17.75 |
| High Target | USD 19 |
| Low Target | USD 16 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (MOBI)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD -0.46 |
| Revenue Estimate | $14.04M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -1.1 vs est -0.8 ▼ miss |
| 2026-03-31 | USD -19.3 vs est -9.91 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (MOBI)
| Total Revenue | $45.28M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +102.40% |
| Gross Margin | +81.75% |
| Operating Margin | -132.74% |
| Profit Margin | -141.63% |
| Debt / Equity | 0.05 |
| Current Ratio | 13.28 |
| Total Cash | $177.09M |
| Total Debt | $8.43M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (MOBI)
Nexqual rates Mobia Medical, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Strong — Revenue +102% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $177M cash vs $8M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$58M (TTM) |
| Efficiency | Mixed — No data |
Ownership (MOBI)
| Insider Ownership | +19.61% |
|---|---|
| Institutional Ownership | +63.06% |
| Shares Outstanding | 33.29M |
| Float | 13.75M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (MOBI)
Mobia Medical, Inc. is led by Richard John Foust (age 51), CEO, President & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| CEO, President & Director | Richard John Foust (age 51) |
|---|---|
| Chief Financial Officer | Nelson Bunker Curnes (age 42) |
| Chief Operating Officer | Prashant B. Rawat (age 51) |
| Co-Founder & Chief Scientific Officer | Navzer Engineer |
| Vice President of Marketing | Philip B. Freed |
Major Backers & Investors (MOBI)
Notable institutional backers of Mobia Medical, Inc. include SR One Capital Management, LP, Farallon Capital Management LLC, Avidity Partners Management, LP, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SR One Capital Management, LP | 5.97% |
| Farallon Capital Management LLC | 3.39% |
| Avidity Partners Management, LP | 2.4% |
| Deerfield Management Company, L.P | 2.01% |
| Aberdeen Group plc | 1.76% |
| Perceptive Advisors Llc | 1.57% |
| abrdn Healthcare Investors | 1.33% |
| Rock Springs Capital Management, LP | 1.26% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.68% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt